693
Views
6
CrossRef citations to date
0
Altmetric
Reviews

Hepatic veno-occlusive disease in allogeneic stem cell transplant recipients with prior exposure to gemtuzumab ozogamicin or inotuzumab ozogamicin

, &
Pages 257-263 | Received 08 Jun 2020, Accepted 08 Sep 2020, Published online: 29 Sep 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Alexis Q. Dean, Shen Luo, Julianne D. Twomey & Baolin Zhang. (2021) Targeting cancer with antibody-drug conjugates: Promises and challenges. mAbs 13:1.
Read now

Articles from other publishers (5)

Andrew C. Johns & Matthew T. Campbell. (2022) Toxicities From Antibody-Drug Conjugates. The Cancer Journal 28:6, pages 469-478.
Crossref
Hiroto Ishii & Shingo Yano. (2022) New Therapeutic Strategies for Adult Acute Myeloid Leukemia. Cancers 14:11, pages 2806.
Crossref
Robert S. Ackerman, Aaron R. Muncey, Nasrin N. Aldawoodi, Rohini Kotha & Rosemarie E. Garcia Getting. (2022) Cancer Immunotherapies: What the Perioperative Physician Needs to Know. Current Oncology Reports 24:4, pages 399-414.
Crossref
Rebecca Kohnken, Hadi Falahatpisheh, Kyathanahalli S. Janardhan & Magali Guffroy. (2021) Anatomic and Clinical Pathology Characterization of Drug-Induced Sinusoidal Obstruction Syndrome (Veno-Occlusive Disease) in Cynomolgus Macaques. Toxicologic Pathology 50:1, pages 13-22.
Crossref
Charanpreet Singh, Nishant Jindal, Padma Youron, Pankaj Malhotra, Gaurav Prakash, Alka Khadwal, Arihant Jain, Sreejesh Sreedharanunni, Man Updesh Singh Sachdeva, Shano Naseem, Neelam Varma, Subhash Varma & Deepesh P. Lad. (2020) Efficacy, safety, and quality of life of generic and innovator ibrutinib in Indian CLL patients. Indian Journal of Hematology and Blood Transfusion 37:2, pages 313-317.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.